Skip to main content Skip to footer

Orexo press releases

AstraZeneca acquires all rights to Orexo´s OX-CLI project

17 March 2016 at 08:00 – Regulatory

AstraZeneca acquires all rights to Orexo´s OX-CLI project

Notice of Annual General Meeting of Orexo

11 March 2016 at 10:00 – RegulatoryGeneral Meeting

Notice of Annual General Meeting of Orexo

Number of shares and votes in Orexo

29 February 2016 at 17:35 – Regulatory

Number of shares and votes in Orexo

Full year report January-December 2015

28 January 2016 at 08:40 – RegulatoryReportQ4

Full year report January-December 2015

New Abstral® partner in the US

20 November 2015 at 15:15

New Abstral® partner in the US

Orexo Settles Abstral® US Patent Litigation with Actavis

27 October 2015 at 08:30 – Regulatory

Orexo Settles Abstral® US Patent Litigation with Actavis

Interim report January-September 2015

22 October 2015 at 08:00 – RegulatoryReportQ3

Interim report January-September 2015

Number of shares and votes in Orexo

31 July 2015 at 08:00 – Regulatory

Number of shares and votes in Orexo

Interim report January-June 2015

10 July 2015 at 08:00 – RegulatoryReportQ2

Interim report January-June 2015

Number of shares and votes in Orexo

30 June 2015 at 18:15 – Regulatory

Number of shares and votes in Orexo

Number of shares and votes in Orexo

29 May 2015 at 17:30 – Regulatory

Number of shares and votes in Orexo

Orexo divests subsidiary Kibion

30 April 2015 at 13:24

Orexo divests subsidiary Kibion

Interim report January-March 2015

23 April 2015 at 08:00 – RegulatoryReportQ1

Interim report January-March 2015

IR & Corporate Communications Director

Lena Wange

Subscribe